title: Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria.
abstract: This hospital based surveillance study evaluates the effects of the rotavirus mass vaccination program, which was initiated in Austria in August 2007. Since then, incidence rates of rotavirus hospitalizations in children <15 years of age have decreased by 70% and 64% in 2010 and 2011 compared to the pre-vaccination era (2001-2005). Incidence rates were highest in children <90 days of age, highlighting the importance of the early start of active rotavirus immunization. In children between 2 and 3.5 years in 2011, who were in the second and third year after vaccination in the universal mass vaccination program, incidence rates remained low suggesting sustained protection after vaccination up to three years. In the years 2010 and 2011, field effectiveness of the vaccines was between 79% and 96%, depending on the assumptions made for children without information on vaccination history. From genotyping an increase of the prevalence of G2P[4] in children with breakthrough infection (disease despite vaccination) can be suspected. The rate of severe adverse events was 1.3-1.5 per 10(-5) administered doses of rotavirus vaccines and no death, intussusception or Kawasaki disease was reported in 2010 and 2011 following rotavirus vaccination.
authors.affiliation: Institute of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Austria.
authors.forename: Maria
authors.initials: M
authors.lastname: Paulke-Korinek
authors.forename: Herwig
authors.initials: H
authors.lastname: Kollaritsch
authors.forename: Stephan W
authors.initials: SW
authors.lastname: Aberle
authors.forename: Ines
authors.initials: I
authors.lastname: Zwazl
authors.forename: Birgit
authors.initials: B
authors.lastname: Schmidle-Loss
authors.forename: Andreas
authors.initials: A
authors.lastname: Vécsei
authors.forename: Michael
authors.initials: M
authors.lastname: Kundi
mesh_terms: D001317:Austria / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005838:Genotype; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007443:Intussusception / Q000453:epidemiology / Q000517:prevention & control; D008297:Male; D032541:Mass Vaccination / Q000706:statistics & numerical data*; D015995:Prevalence; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000453:epidemiology* / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology
chemical_list: D022243:Rotavirus Vaccines